|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [687]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [687]
to other disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1393–1400.
Lavigne, J. V., Gibbons, R. D., Christoffel, K. K., Arend, R., Rosenbaum, D., Binns, H., et al. (1996). Prevalence rates and correlates of psychiatric disorders among preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 204–214.
Layne, C. M., Pynoos, R. S., & Cardenas, J. (2001). Wounded adolescence: School-based group psychotherapy for adolescents who sustained or witnessed violent injury. In M. Shafi & S. L. Shafi (Eds.), School violence: Assessment, management, prevention. Washington, DC: American Psychiatric Association.
Layne, C. M., Pynoos, R. S., Saltzman, W. R., Arslanagic, B., Black, M., Savjak, N., et al. (2001). Trauma/grief-focused group psychotherapy: School-based postwar intervention with trau-matized Bosnian adolescents. Group Dynamics, 5, 277–290.
Leckman, J. F., & Mayes, L. C. (1998). Understanding developmental psychopathology: How useful are evolutionary accounts? Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1011–1021.
Lecrubier, Y., Bakker, A., Dunbar, G., & Judge, R. (1997). A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica, 95, 145–152.
LeDoux, J. E. (1996). The emotional brain. New York: Simon & Schuster.
Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Cheslow, D. L., Hamburger, S. D., et al. (1991). A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive compulsive disorder. Archives of General Psychiatry, 48, 922–926.
Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Hamburger, S. D., Bartko, J. J., et al. (1993). A 2-to 7-year follow-up study of 54 ob
sessive compulsive children and adolescents. Archives of General Psychiatry, 50, 429–439.
Leonard, H. L., Swedo, S., Rapoport, J. L., Koby, E. V., Lenane, M. C., Cheslow, D. L., et al. (1989). Treatment of obsessive compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088–1092.
Leonard, H. L., Topol, D., Bukstein, O., Hindmarsh, D., Allen, A. J., & Swedo, S. E. (1994). Clonazepam as an augmenting agent in the treatment of childhood onset obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 792–794.
Lewinsohn, P. M., Gotlib, I. H., Lewinsohn, M., Seeley, J. R., & Allen, N. B. (1998). Gender differences in anxiety disorders and anxiety symptoms in adolescents. Journal of Abnormal Psychology, 107, 109–117.
Lewinsohn, P., Zinbarg, J., Seeley, J. R., Lewinsohn, S., & Sack, W. H. (1997). Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents. Journal of Anxiety Disorders, 14, 377– 394.
Liebowitz, M. R., Schneier, R., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., et al. (1992). Phenelzine vs. atenolol in social phobia. Archives of General Psychiatry, 49, 290–300.
Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. O., Graue, F., et al. (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry41, 1431–1438.
Lin, K. M. (2001). Biological differences in depression and anxiety across races and ethnic groups. Journal of Clinical Psychiatry 62 (Suppl. 13), 13–19; discussion 20–21.
end p.687
|
|
|
|
